OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer Jul 17, 2018 8:00am EDT
OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer Jul 16, 2018 8:00am EDT
OncoSec Presents Update on PISCES/KEYNOTE-695 Phase 2b Registration-Directed Clinical Trial in Combination with Merck's KEYTRUDA® for Metastatic Melanoma at the ASCO 2018 Annual Meeting Jun 04, 2018 8:00am EDT
OncoSec Expands Relationship with Merck, Announces Clinical Collaboration to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer May 08, 2018 7:30am EDT
OncoSec Announces PISCES/KEYNOTE-695 Trial-in-Progress Poster Presentation at Upcoming ASCO 2018 Annual Meeting Apr 26, 2018 8:00am EDT
OncoSec Provides Highlights from Research Reception at AACR Annual Meeting 2018 Apr 16, 2018 8:35am EDT
